Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Equity (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Equity for 14 consecutive years, with 9.13% as the latest value for Q4 2025.

  • For Q4 2025, Return on Equity fell 1759.0% year-over-year to 9.13%; the TTM value through Dec 2025 reached 9.13%, down 1759.0%, while the annual FY2025 figure was 1.11%, 1248.0% down from the prior year.
  • Return on Equity hit 9.13% in Q4 2025 for Traws Pharma, down from 2.47% in the prior quarter.
  • Across five years, Return on Equity topped out at 11.11% in Q1 2025 and bottomed at 9.13% in Q4 2025.
  • Average Return on Equity over 5 years is 0.05%, with a median of 0.62% recorded in 2021.
  • On a YoY basis, Return on Equity climbed as much as 1343bps in 2025 and fell as far as -1759bps in 2025.
  • Traws Pharma's Return on Equity stood at 0.34% in 2021, then crashed by -85bps to 0.64% in 2022, then plummeted by -153bps to 1.61% in 2023, then soared by 625bps to 8.46% in 2024, then plummeted by -208bps to 9.13% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 9.13%, 2.47%, and 2.84% for Q4 2025, Q3 2025, and Q2 2025 respectively.